Illicit drugs are big business. They are one of the main profit-generating activities of organised crime and are estimated to represent around one-fifth of global crime proceeds. The negative impacts of illicit drug markets are multifaceted and far-reaching, which is why they remain a key threat to the security of the European Union and the safety of its citizens.
Ahead of the United Nations General Assembly Special Session on Drugs (UNGASS), two EU agencies — Europol and the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) — will release their latest state-of-the-art report on the EU drug market, providing a detailed analysis of this important policy-relevant field.
The 2016 EU Drug Markets Report — In-depth Analysis will be launched at a press conference in Brussels on 5 April by Dimitris Avramopoulos, European Commissioner for Migration, Home Affairs and Citizenship. The Commissioner will be joined by Europol Director Rob Wainwright and EMCDDA Director Alexis Goosdeel.
Tags
- Analysis
- Strategic
- Press Release/News
- Event
- European Union Drugs Agency (EUDA)